title: Antidepressants in the postpartum period: additional considerations.
authors.forename: Rachel
authors.initials: R
authors.lastname: Burbeck
authors.forename: Stephen
authors.initials: S
authors.lastname: Pilling
authors.forename: Dave
authors.initials: D
authors.lastname: Tomson
authors.forename: Liz
authors.initials: L
authors.lastname: McDonald
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001942:Breast Feeding / Q000009:adverse effects; D019052:Depression, Postpartum / Q000188:drug therapy* / Q000628:therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D017374:Paroxetine / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000628:therapy; D011613:Psychotherapy / Q000379:methods; D018570:Risk Assessment; D020230:Serotonin Syndrome / Q000139:chemically induced / Q000175:diagnosis; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000209:etiology
chemical_list: D000928:Antidepressive Agents; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors